A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Non Small Cell Lung Cancer|Breast Cancer
Interventions: DRUG: Abemaciclib|DRUG: Pembrolizumab|DRUG: Anastrozole
Sponsor: Eli Lilly and Company
Collaborators: Merck Sharp & Dohme LLC